Parallel synthesis and antileishmanial activity of ether-linked phospholipids.

[1]  Simon Croft,et al.  Kinetoplastids: related protozoan pathogens, different diseases. , 2008, The Journal of clinical investigation.

[2]  A. Detsi,et al.  Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives. , 2008, Journal of medicinal chemistry.

[3]  J. Saugar,et al.  Synthesis and biological evaluation of fluorescent leishmanicidal analogues of hexadecylphosphocholine (miltefosine) as probes of antiparasite mechanisms. , 2007, Journal of medicinal chemistry.

[4]  F. Mollinedo.  Antitumour ether lipids: proapoptotic agents with multiple therapeutic indications , 2007 .

[5]  Sarman Singh,et al.  Chemotherapy of leishmaniasis: past, present and future. , 2007, Current medicinal chemistry.

[6]  Agnes Kapou,et al.  3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids. , 2007, Bioorganic & medicinal chemistry.

[7]  V. Yardley,et al.  Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: In Vitro, In Vivo, Structure-Activity Relationship, and Quantitative Structure-Activity Relationship Studies , 2006, Antimicrobial Agents and Chemotherapy.

[8]  Michael P Barrett,et al.  Chemotherapy of trypanosomiases and leishmaniasis. , 2005, Trends in parasitology.

[9]  H. Sindermann,et al.  Oral miltefosine for leishmaniasis in immunocompromised patients: compassionate use in 39 patients with HIV infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  S. Croft,et al.  Antiprotozoal lysophospholipid analogues: a comparison of their activity against trypanosomatid parasites and tumor cells. , 2004 .

[11]  S. Grdadolnik,et al.  Antileishmanial ring-substituted ether phospholipids. , 2003, Journal of medicinal chemistry.

[12]  S. Croft,et al.  Antiprotozoal activities of phospholipid analogues. , 2003, Molecular and biochemical parasitology.

[13]  B. Herwaldt.  Miltefosine--the long-awaited therapy for visceral leishmaniasis? , 1999, New England Journal of Medicine.

[14]  W. Reutter,et al.  Mechanisms of action of phospholipid analogs as anticancer compounds. , 1999, Progress in lipid research.

[15]  F. Mollinedo,et al.  Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L). , 1997, Cancer research.

[16]  V. Yardley,et al.  The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. , 1996, The Journal of antimicrobial chemotherapy.

[17]  R. Wahl,et al.  Synthesis and biological evaluation of radioiodinated phospholipid ether stereoisomers. , 1995, Journal of Medicinal Chemistry.

[18]  P. Workman,et al.  Phospholipid antitumor agents , 1995, Medicinal research reviews.

[19]  H. Brachwitz,et al.  Analogs of alkyllysophospholipids: chemistry, effects on the molecular level and their consequences for normal and malignant cells. , 1995, Pharmacology & therapeutics.

[20]  Jonathan A. Ellman,et al.  Straightforward and general method for coupling alcohols to solid supports , 1994 .

[21]  H. Rapoport,et al.  Solid-phase organic synthesis: novelty or fundamental concept? , 1976 .